Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 May 30;15(5):e39687.
doi: 10.7759/cureus.39687. eCollection 2023 May.

Neurological Features and Their Association With Gender in Diabetes Mellitus Patients

Affiliations

Neurological Features and Their Association With Gender in Diabetes Mellitus Patients

Muhammad Mubeen et al. Cureus. .

Abstract

Introduction Understanding the wide range of clinical signs and symptoms associated with diabetes mellitus (DM) is crucial because people with DM are frequently misdiagnosed, given incorrect care, or poorly controlled. Therefore, the purpose of this study was to evaluate the neurological symptoms associated with type 1 and type 2 DM patients with respect to patient gender. Methods This was a cross-sectional multicenter study that was conducted at different hospitals using a non-probability sampling method. The duration of the study was eight months, from January 2022 to August 2022. The study involved 525 type 1 and type 2 DM patients with an age range from 35 to 70 years. Demographic details such as age, gender, socioeconomic status, past medical history, presence of comorbidities, type, and duration of DM, and neurological features were recorded as frequencies and percentages. A Chi-square test was used to determine the association between neurological symptoms associated with type 1 and type 2 DM and gender. Results The study findings showed that of 525 diabetic patients, 210 (40.0%) were females and 315 (60.0%) were males. The mean male and female mean ages were 57.36±14.99 and 50.52±14.8 years, respectively, with a significant difference with respect to gender (p<0.001). The prevalence of neurological manifestations showed that irritability or mood swings were reported by most of the male 216 (68.6%) and 163 (77.6%) female diabetic patients, with a significant association noticed (p=0.022). Moreover, a significant association was observed between both genders in terms of swelling of feet, ankles, hands, and eyes (p=0.042), confusion or difficulty in concentration (p=0.040), burning pain in feet or legs (p=0.012), and muscular pain or cramps in legs or feet (p=0.016). Conclusion This study concluded that the prevalence of neurological manifestations was high among diabetic patients. Most of the neurological symptoms were significantly more pronounced in female diabetic patients. Moreover, most of the neurological symptoms were associated with the type (type 2 DM) and duration of DM. The presence of hypertension, dyslipidemia, and smoking also influenced some neurological manifestations.

Keywords: diabetes type 2; gender; swelling and burning; tingling or numbness; type 1 diabetes.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

References

    1. Diabetes mellitus statistics on prevalence and mortality: facts and fallacies. Zimmet P, Alberti KG, Magliano DJ, Bennett PH. Nat Rev Endocrinol. 2016;12:616–622. - PubMed
    1. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9(th) edition. Saeedi P, Petersohn I, Salpea P, et al. Diabetes Res Clin Pract. 2019;157:107843. - PubMed
    1. Central nervous system: a conductor orchestrating metabolic regulations harmed by both hyperglycaemia and hypoglycaemia. Scheen AJ. Diabetes Metab. 2010;36 Suppl 3:0–8. - PubMed
    1. The impact of diabetes on cerebral structure and function. Seaquist ER. Psychosom Med. 2015;77:616–621. - PMC - PubMed
    1. Neuropathy among the diabetes control and complications trial cohort 8 years after trial completion. Martin CL, Albers J, Herman WH, et al. Diabetes Care. 2006;29:340–344. - PMC - PubMed

LinkOut - more resources